ArticleFrontiers in oncology2024

Multiple immune-related adverse events secondary to checkpoint inhibitor therapy in patients with advanced cancer: association with treatment effectiveness.

Cecilia Olsson Ladjevardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.